-
SPAC Target Focus
-
Healthcare & Medical
-
Expected Close Date
-
March 17, 2023
-
IPO Date
-
2021-03-17
-
IPO Size(M)
-
$ 550M
-
Underwriters
-
Morgan Stanley
Management
Jeff Leiden (Exec Chairman/Fmr CEO, Vertex Pharmaceuticals; Fmr COO, Abbott Laboratories), Robert Nelsen (Co-founder/Managing Director, ARCH), Jennifer Schneider (Fmr Pres/Chief Medical Officer, Livongo Health), Hemant Taneja (Managing Director, General Catalyst)
Management Team / Advisory Board Bios
Jeff Leiden (Exec Chairman/Fmr CEO, Vertex Pharmaceuticals; Fmr COO, Abbott Laboratories), Robert Nelsen (Co-founder/Managing Director, ARCH), Jennifer Schneider (Fmr Pres/Chief Medical Officer, Livongo Health), Hemant Taneja (Managing Director, General Catalyst)